TTYH1 and central nervous system cancer: Notably, TTYH1 shRNA knockdowns in glioblastoma cell lines caused reduced glioma invasiveness, abnormal neurite membrane protrusion morphology, decreased tumor size, and increased survival in mice (Jung et al., 2017).